$1.30
-0.14-9.72%
At close: -
$1.33
0.032.30%
After Hours: 4:02 PM EDT
Comments
Loading...
Regulus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RGLS | Benzinga
Regulus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.230
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Regulus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RGLS | Regulus Therapeutics | -$0.29 | -$0.23 | — | — | $0.00 | — | — | — | 05/08/2025 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.23 | -$0.20 | 13.04% | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.17 | -$0.21 | -23.53% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.37 | -$0.13 | -$0.17 | -30.77% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.42 | -$0.21 | -$0.29 | -38.10% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.39 | -$0.40 | -2.56% | $0.00 | — | $0.00 | — | 03/21/2024 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.40 | -$0.40 | 0.00% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.41 | -$0.37 | 9.76% | $0.00 | — | $0.00 | — | 08/08/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.50 | -$0.44 | -$0.42 | 4.55% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.70 | -$0.51 | -$0.40 | 21.57% | $0.00 | — | $0.00 | — | 03/23/2023 | Get Alert |
| RGLS | Regulus Therapeutics | -$1.00 | -$0.49 | -$0.50 | -2.04% | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.80 | -$0.50 | -$0.50 | 0.00% | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.30 | -$0.70 | -$0.70 | 0.00% | $5.00M | — | $0.00 | — | 03/10/2022 | Get Alert |
| RGLS | Regulus Therapeutics | -$0.40 | -$0.80 | -$1.00 | -25.00% | $5.00M | — | $0.00 | — | 11/10/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.30 | -$0.80 | -$0.80 | 0.00% | $0.00 | $10.00K | $0.00 | -100.00% | 08/10/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.50 | -$0.90 | -$0.80 | 11.11% | $6.00K | $20.00K | $0.00 | -100.00% | 05/13/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.30 | — | -$0.30 | — | $18.00K | — | $5.00M | — | 03/09/2021 | Get Alert |
| RGLS | Regulus Therapeutics | -$2.60 | -$2.10 | -$0.40 | 80.95% | $18.00K | $340.00K | $5.00M | 1370.59% | 11/05/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$3.00 | — | -$2.30 | — | $18.00K | — | $0.00 | — | 08/13/2020 | Get Alert |
| RGLS | Regulus Therapeutics | -$3.10 | — | -$2.50 | — | $6.78M | — | $6.00K | — | 05/14/2020 | Get Alert |
Regulus Therapeutics (RGLS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.20 | $-0.23 | 13.0 % |
| Q3 | 2024-11-07 | $-0.21 | $-0.17 | -23.5 % |
| Q2 | 2024-08-08 | $-0.17 | $-0.13 | -30.8 % |
| Q1 | 2024-05-09 | $-0.29 | $-0.21 | -38.1 % |
Regulus Therapeutics (RGLS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2021-08-10 | $0 | $10.00K | -100.0 % |
| Q1 | 2021-05-13 | $0 | $20.00K | -100.0 % |
| Q3 | 2020-11-05 | $5.00M | $340.00K | 1370.6 % |
FAQ
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics (RGLS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Regulus Therapeutics (NASDAQ:RGLS)?
The Actual EPS was $-0.20, which beat the estimate of $-0.23.
What were Regulus Therapeutics’s (NASDAQ:RGLS) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.